cb-010,fludarabine,cyclophosphamide
Caribou Biosciences
['car-t', 'ribo']
$crbu [15s. delayed]: issued press release on june 10, 03:00:00: caribou biosciences reports positive additional data from cb-010 allogeneic car-t cell therapy phase 1 antler trial at the european hematology association (eha) 2022 hybrid congress 
Flash Alert is a low-latency financial news service which sources SEC, press releases, credible news sources to get your news about stocks in near real-time